MEDIFAST, INC. (NYSE:MED) Files An 8-K Regulation FD Disclosure

MEDIFAST, INC. (NYSE:MED) Files An 8-K Regulation FD Disclosure

Story continues below

Item 7.01.

Regulation FD Disclosure.

On June 5, 2017, Daniel R. Chard, Chief Executive Officer of
Medifast, Inc. (the Company), will make a presentation at the
Direct Selling Association 2017 Annual Meeting in Orlando,
Florida. Mr. Chard will make his presentation at 1:35 EDT. A copy
of the presentation is furnished as Exhibit 99.1 to this Current
Report on Form 8-K and will be archived online on the Investor
Relations section of the Companys website at through June 19, 2017.

The information contained in the presentation is summary
information that should be considered in the context of the
Companys filings with the Securities and Exchange Commission (the
SEC) and other public announcements the Company may make by press
release or otherwise from time to time. The Company undertakes no
duty or obligation to publically update or revise the information
in the presentation, although it may do so from time to time as
its management believes is warranted. Any such updating may be
made through the filing of other reports or documents with the
SEC, through press releases or through other public disclosure.

The information presented in Item 7.01 of this Current Report on
Form 8-K, and Exhibit 99.1, shall not be deemed to be filed for
purposes of Section 18 of the Securities Exchange Act of 1934, as
amended (the Exchange Act), or otherwise subject to the
liabilities of that section, unless the Company specifically
states that the information is to be considered filed under the
Exchange Act or specifically incorporates it by reference into a
filing under the Securities Act of 1933, as amended, or the
Exchange Act.

Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
99.1 Presentation dated June 5, 2017.


Medifast, Inc. (Medifast) is engaged in the production, distribution and sale of weight loss, weight management and healthy living products, and other consumable health and diet products. The Company operates through its subsidiaries, Jason Pharmaceuticals, Inc., Take Shape For Life, Inc., Jason Enterprises, Inc., Medifast Franchise Systems (MFSI), Inc., Jason Properties, LLC, Medifast Nutrition, Inc. and Seven Crondall, LLC. Its product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins. It provides weight loss, weight management and healthy living products and programs through multiple channels of distribution: direct to consumer channel through its Website and in-house call centers; Take Shape For Life; Franchise Medifast Weight Control Centers, and a national network of physicians. It offers its products under the Medifast, Thrive by Medifast, Optimal Health by Take Shape For Life and Essential 1 brands.

An ad to help with our costs